Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check24 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check31 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check38 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.